Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10812	Companies
234245	Keywords
163041	Articles
125260	Press releases

Home
Companies
Biophytis

PRESS RELEASE

published on 06/12/2024 at 10:11, 2 years 1 month ago

Biophytis annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens
Biophytis annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens. La société se focalise sur le traitement de maladies liées à l'âge, notamment la Dystrophie Musculaire de Duchenne

Biophytis BIO101 Seqens Transfert Industriel DMD
PRESS RELEASE

published on 06/12/2024 at 10:11, 2 years 1 month ago

Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens
Biophytis successfully transfers BIO101 (20-hydroxyecdysone) production to industrial scale with Seqens, enhancing therapeutic solutions for Duchenne Muscular Dystrophy patients

Biophytis Duchenne Muscular Dystrophy BIO101 Seqens 20-hydroxyecdysone
BRIEF

published on 06/12/2024 at 07:05, 2 years 1 month ago

Biophytis annonce le succès du transfert de production de BIO101 par Seqens

Biophytis Dystrophie Musculaire De Duchenne BIO101 Seqens Production Industrielle
BRIEF

published on 06/12/2024 at 07:05, 2 years 1 month ago

Biophytis Announces Successful Industrial Transfer of BIO101 Production by Seqens

Biophytis Clinical Trial Duchenne Muscular Dystrophy BIO101 Seqens
REGULATED PRESS RELEASE

published on 06/12/2024 at 07:00, 2 years 1 month ago

Biophytis annonce le succès du transfert industriel de production de BIO101 (20-hydroxyecdysone) par son prestataire Seqens
Biophytis annonce le succès du transfert industriel de production de BIO101 par Seqens, renforçant ainsi son programme de développement clinique pour traiter la Dystrophie Musculaire de Duchenne (DMD)

Biophytis Dystrophie Musculaire De Duchenne BIO101 Seqens Transfert Industriel
REGULATED PRESS RELEASE

published on 06/12/2024 at 07:00, 2 years 1 month ago

Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens
Biophytis announces successful industrial transfer of BIO101 (20-hydroxyecdysone) production by Seqens for DMD treatment. Collaboration strengthens therapeutic solutions and accelerates clinical programs

Biophytis Clinical Development Duchenne Muscular Dystrophy BIO101 Seqens
BRIEF

published on 06/10/2024 at 08:23, 2 years 1 month ago

Biophytis dépose une demande d'IND pour une étude de phase 2 dans l'obésité

Biophytis Phase 2 BIO101 Obésité IND
BRIEF

published on 06/10/2024 at 08:23, 2 years 1 month ago

Biophytis Files IND Application for Phase 2 Obesity Study with US FDA

FDA Biophytis Clinical Study Obesity IND Application
BRIEF

published on 06/10/2024 at 08:21, 2 years 1 month ago

Biophytis dépose une demande d'IND pour une étude de phase 2 dans l'obésité

FDA Biophytis Phase 2 BIO101 Obésité
BRIEF

published on 06/10/2024 at 08:21, 2 years 1 month ago

Biophytis files IND application for phase 2 study in obesity

FDA Biophytis Phase 2 BIO101 Obesity

Accesswire

Published on 08/08/2026 at 00:00, 1 day 13 hours ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 1 day 14 hours ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 1 day 14 hours ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 1 day 15 hours ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 1 day 15 hours ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/09/2026 at 00:01, 13 hours 43 minutes ago

Club Offers for Travel Enthusiasts in Germany
Published on 08/08/2026 at 16:25, 21 hours 18 minutes ago

Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 1 day 14 hours ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 1 day 18 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 1 day 18 hours ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries

Les Echos

Published on 08/07/2026 at 18:54, 1 day 18 hours ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 1 day 18 hours ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 1 day 19 hours ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 1 day 19 hours ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day 19 hours ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE